MaxCyte Inc (FRA:MYE0)
€ 3.78 0 (0%) Market Cap: 431.11 Mil Enterprise Value: 301.09 Mil PE Ratio: 0 PB Ratio: 2.22 GF Score: 62/100

MaxCyte Inc at Stephens Investment Conference (Virtual) Transcript

Nov 29, 2021 / 05:00PM GMT
Release Date Price: €8.4 (+9.09%)
Jacob Johnson
Stephens Inc. - Analyst

Good morning, everybody. Welcome to day one of the Stephens Investment Conference. I'm Jacob Johnson, life science tools and diagnostics analyst here at Stephens. Really delighted to be joined by the team from MaxCyte. We've got CEO, Doug Doerfler today with us; along with Sean Menarguez from Investor Relations.

(Conference Instructions) And with that out of the way, Doug, I'll turn it over to you for some opening comments, and then we'll launch into Q&A.

Doug Doerfler
MaxCyte, Inc. - President & CEO

Well, thanks, Jacob. It is really a pleasure to be here, our first Stephens Conference and obviously virtual. And thank you for you and your team's support during this incredible process as a public company. So thanks, Jacob. Looking forward to today's discussion. Thank you.

Questions & Answers

Jacob Johnson
Stephens Inc. - Analyst

Short and sweet. I like it, Doug. So maybe to kick things off, for those who may be less familiar with MaxCyte and the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot